Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank43
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-22.71M
↓ 40% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-16.23M
Historical baseline
PeriodValueYoY Change
TTM$-22.71M+24.0%
2024$-29.88M+23.8%
2023$-39.21M-62.6%
2022$-24.11M-138.6%
2021$-10.10M-333.9%
2020$-2.33M-519.4%
2019$-376014.00+66.5%
2018$-1.12M-